XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows From Operating Activities    
Net loss $ (10,994,927) $ (15,103,722)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,587,477 844,091
Equity based compensation expense 3,573,562 5,076,167
Gain or loss on fair value of marketable securities 111,368 246,532
Change in fair value of warrant liability 1,503 (72,755)
Change in fair value of contingent consideration 1,154,528 0
Change in fair value of derivative liability 17,680 0
Bad debt (recovery) expense 6,874 (85,535)
Impairment expense (0) 24,881
Loss on shares issued in settlement of consulting agreement 0 152,629
Loss on debt settlement 0 8,521,149
(Gain) on assets sale 0 (1,763,430)
Amortization of debt discount and debt costs 0 177,072
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable (1,022,625) 451,844
Decrease in prepaid expenses and other current assets 389,631 99,101
Increase (decrease) in accounts payable and accrued liabilities 1,133,139 (230,885)
(Decrease) in deferred revenue (9,204) (44,431)
Net cash (used) in operating activities (4,050,994) (1,707,292)
Cash Flows From Investing Activities:    
Purchase of intangible assets (400,000) 0
Proceeds from sale of assets 0 1,763,430
Net cash (used in) provided by investing activities (400,000) 1,763,430
Cash Flows From Financing Activities:    
Proceeds from sale of common stock in offering 1,840,500 2,230,975
Proceeds from line of credit payable 200,000 0
Payments of promissory notes 0 (592,057)
Repayments of notes 0 (1,071,552)
Gross proceeds from exercise of warrants 0 592,057
Net cash provided by financing activities 2,040,500 1,159,423
Net decrease in cash (2,410,494) 1,215,561
Cash, beginning of period 2,532,990 1,008,408
Cash, end of period 122,496 2,223,969
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 0 150,461
Cash paid during the period for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Issuance of common stock upon purchase of intangible assets 11,209,845 647,055
Stock to be issued for fixed consideration 1,000,000 0
Issuance of common stock upon debt conversion 1,496,886 0
Warrants issued in connection with purchase of intangible assets 0 480,358
Issuance of common stock issued upon conversion of note payable 0 273,673
Issuance of common stock from conversion of Preferred stock, Series E 0 9
Issuance of common stock upon exercise of warrants and conversion of debt 0 1,115,437
Issuance of common stock for debt settlements $ 0 $ 11,029,647